CRM Overweight: Stage entry plan with $189 hard stop; full sizing deferred until earnings and macro binaries resolve
CRM is a measured Overweight with correct directional thesis but empirical support for staged accumulation over full-size initiation. Hard stop at $189 (2.6x ATR) is ATR-anchored per technical report; stop at $200 (1.25x ATR) rejected per data showing it gets shaken out on routine volatility. Three-stage plan honors all prior lessons: not scaling aggressively into binary (8/14), not skipping Stage 1 (8/17/8/18), and letting catalyst resolve directional bias (8/19/8/20). Price target $230 with 13.5x forward P/E and 9.7% FCF yield supports upside; $27B debt-funded buyback and rising D/E require post-earnings confirmation. Full deployment awaits cleaner setup post-catalyst.
| Position | Action |
|---|---|
| Stage 1 (today): 0.3-0.5% of risk capital | Deploy via limit orders at $209-210 |
| Stage 2 trigger: Confirmed close above 20 SMA ($192-198 zone) with RSI below 55 OR bullish reversal candle on volume >10M shares | Deploy 0.8-1.0% of risk capital |
| Stage 3 trigger: Post-earnings beat-and-raise with cRPO acceleration AND FCF margin durability | Deploy remaining 0.4-0.5% of risk capital |
| Total position cap | Cap at 1.5% of risk capital until higher base forms above $210 |
| Price reaches $220-225 with strength extending into earnings | Trim 10-20% to monetize conviction |
Salesforce at $209 is the most asymmetric risk/reward setup in mega-cap software due to cheap valuation (13.5x forward P/E, 9.7% FCF yield), re-accelerating growth (13.3% YoY in Q1 FY27), and the Agentforce AI product hitting $1B ARR, with a Q2 FY27 earnings catalyst priced at 92% beat probability.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 199.45 | bullish |
| 50 SMA | 174.59 | bullish |
| 200 SMA | 200.06 | bullish |
| MACD | +8.35 | bullish |
| MACD Signal | +7.29 | bullish |
| MACD Histogram | +1.06 | bullish |
| RSI | 66.16 | neutral |
| Bollinger Upper Band | 210.76 | neutral |
| Bollinger Middle Band | 192.57 | neutral |
| Bollinger Lower Band | 174.37 | neutral |
| ATR | 8.06 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above 20 SMA ($192-198 zone) with RSI resetting below 55 OR bullish reversal candle on volume >10M shares
Then: Deploy 0.8-1.0% of risk capital
↩ rebuts: “Bear Argument #4: 'Valuation is stretched given only 9-10% growth'”
EV: +25-35%
CRM at $209 is a sell—the "cheap at 13.5x forward P/E" is the most dangerous trap in software right now, built on heroic EPS assumptions, a debt-funded buyback that signals defense not conviction, and an extended technical setup heading into a cluster of three binary events in 72 hours.
· concedes: The bull case is well-constructed and the data is real; Agentforce crossing $1B ARR is genuinely impressive for a product line this young; The current stock price of $209 is down from a 52-week high of $269, representing meaningful mean reversion
→ vs conservative: Recommending HOLD on RSI at 66 and 50 SMA gap of 20% while ignoring 5 aligned bullish indicators; 'wait for $192 pullback' has only ~25% fill probability given buyback wall
→ vs conservative: YTD drawdown is a gift, not a warning; 35% FCF margin and 21.5% operating margin at 13.5x forward P/E is cheapest valuation in years as AI product cycle inflects
→ vs conservative: Calling for ZERO exposure versus trader's disciplined 1.5% portfolio cap with asymmetric upside; worst-case is small contained loss, best-case is 30% return on generational AI-platform re-rating
→ vs neutral: Recommending HOLD with slight buy bias despite citing 92% Polymarket beat probability; treating near-certain beat as 50/50 coin flip is analytical inconsistency
→ vs neutral: 'Wait for confirmation' strategy produces 5% returns while stock sets up for 30%; by time RSI cools and Bollinger bands reset, entry will be 10-15% higher
| VWMA | 196.25 | bullish |
Support: 192.57 · 193 · 174.37 | Resistance: 200.06 · 210.76
CRM is in a confirmed bullish recovery following a 6-month selloff (Jan–Jun 2026), having rallied from ~$146 to $209.17. All trend filters align bullish: price sits above the 10 EMA (+4.9%), 50 SMA (+19.8%), and 200 SMA (+4.6%), while MACD is strongly positive at +8.35 with histogram expanding to +1.06. However, the stock is tactically extended—RSI at 66.16 approaches the 70 overbought threshold and price is virtually touching the upper Bollinger band at $210.76. ATR of $8.06 indicates elevated daily volatility (~3.9% typical swings), warranting wide stop-loss placement. A healthy 5–10% pullback toward the $190–$195 zone (20 SMA/VWMA) would offer better risk/reward for new entries. Final recommendation: HOLD, with suggested stop-loss zone at $193 and trail stop for existing longs near $200.
Market Cap
$171.31 B
P/E (TTM)
24.24x
Forward P/E
13.48x
PEG Ratio
0.86
P/B
5.00x
EPS (TTM)
$8.63
Forward EPS
$15.52
Dividend Yield
0.86%
FCF Yield
9.7%
Revenue FY2026
$41,525 million
Revenue Growth FY2026
+9.6%
Gross Margin FY2026
77.7%
Operating Income FY2026
$8,917 million
Operating Margin FY2026
21.5%
Net Income FY2026
$7,457 million
Diluted EPS FY2026
$7.80
EBITDA FY2026
$12,548 million
Revenue Q1 FY2027
$11,133 million
Revenue Growth Q1 FY2027
+13.3%
Operating Margin Q1 FY2027
21.8%
Net Income Q1 FY2027
$2,107 million
Diluted EPS Q1 FY2027
$2.42
Free Cash Flow Q1 FY2027
$6,556 million
Free Cash Flow FY2026
$14,402 million
FCF Margin FY2026
34.7%
CapEx FY2026
$594 million
Operating Cash Flow FY2026
$14,996 million
Cash & ST Investments FY2026
$9,565 million
Total Debt
$17,176 million
Net Debt
$7,112 million
Goodwill
$64,756 million
Stockholders' Equity
$59,142 million
Deferred Revenue
$24,320 million
Return on Equity
16.9%
Net Profit Margin (TTM)
18.7%
EBITDA Margin (TTM)
30.1%
Q1 FY2027 Buybacks
$27,250 million
FY2026 Share Repurchases
$12,596 million
FY2026 Dividends Paid
$1,587 million
52-Week High
$269.11
52-Week Low
$146.32
50-Day Moving Avg
$173.83
200-Day Moving Avg
$201.08
Beta
1.152
Strengths
Concerns
Salesforce (CRM) is a cloud-based CRM leader generating $41.5B in FY2026 revenue with an elite 34.7% FCF margin, having grown free cash flow 128% over three years ($6.3B to $14.4B) while expanding operating margins from 5.9% to 21.5%. The stock is unusually cheap at a 13.5x forward P/E with a 9.7% FCF yield, particularly compelling given Q1 FY2027's revenue re-acceleration to 13.3% YoY and the recently announced $27.2B buyback (~16% of market cap), though risks include negative tangible book value, elevated leverage post-borrowing, and competition in the AI era.
Macro: Soft-landing remains the dominant macro narrative with only 8% US recession probability by year-end 2026. The Fed is priced to stay put (85% no cuts in 2026) with sticky rates and resilient growth — neutral-to-supportive for large-cap software but constraining multiple expansion. Jackson Hole (8/28) is the week's largest macro catalyst, with Polymarket pricing 70% probability Chair Warsh uses 'Challenge' in a potentially hawkish framing. Geopolitical tailwinds (Iran de-escalation) are relieving oil-driven inflation pressures.